Stay updated on RX-5902 in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RX-5902 in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The RX-5902 clinical trial record is displayed with details about the study, its participants and locations, treatment plan, and measured outcomes. It also identifies the study as terminated and no longer recruiting participants.
    Difference
    45%
    Check dated 2026-11-07T13:39:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2, while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-31T14:41:47.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH-wide notice appears above the page, linking to transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:09:37.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:47:47.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The study-record page displays a 403 Forbidden message with a Home link, and the site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.6%
    Check dated 2026-10-10T15:46:55.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study record content with a minimal header and a Home link, indicating the page is currently inaccessible.
    Difference
    0.5%
    Check dated 2026-09-26T17:31:22.000Z thumbnail image

Stay in the know with updates to RX-5902 in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.